Corporate news - Gerresheimer

Corporate news

Centor is the clear market leader in the US prescription plastic vial retail market for oral drugs The deal extends Gerresheimer’s footprint in the…
Read more
Revenues up 6.3% to EUR 356.4m (1.9% on an organic basis) Adjusted EBITDA rises 10.6% to EUR 72.1m Net income grows by 7.4% to EUR 22.4m Earnin…
Read more
Gerresheimer will sell its borosilicate glass tubing business to Corning Corning and Gerresheimer enter into a 10-year-supply agreement for…
Read more
Increase in dividend to EUR 0.75 per share Large majority for resolution approving work of Management Board and Supervisory Board Gerresheimer…
Read more
Duesseldorf, April 30, 2015 – At its meeting following today’s Annual General Meeting, the Supervisory Board of Gerresheimer AG elected Dr. Axel…
Read more
Revenues up 1.4% to EUR 301.8m (organic growth -2.4%) Adjusted EBITDA growth of 7.2% to EUR 51.0m (Q1 2014: EUR 47.6m) Net income climbs 22.8% to…
Read more
Revenues up 1.9% (3.7% organically) to EUR 1,290.0m Adjusted EBITDA totals EUR 258.5m at constant exchange rates Earnings per share up 6.6% to…
Read more
Düsseldorf/Dongguan City (People’s Republic of China), October 22, 2014 – Gerresheimer AG, an internationally leading partner to the pharma and…
Read more
Gerresheimer sees good growth opportunities in long-term megatrends of pharma and healthcare Growing importance of drug delivery and dosage devices…
Read more

Contact us!

Communication & Marketing
Phone: +49 211 61 81 251
E-Mail: ueli.utzinger-remove@remove-gerresheimer.com